BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nikitin ES, Vinogradova LV. Potassium channels as prominent targets and tools for the treatment of epilepsy. Expert Opin Ther Targets 2021;25:223-35. [PMID: 33754930 DOI: 10.1080/14728222.2021.1908263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Liang P, Zhang Y, Wu Y, Song Y, Wang X, Chen T, Peng B, Liu W, Yin J, Han S, He X. Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy. IJMS 2022;23:14693. [DOI: 10.3390/ijms232314693] [Reference Citation Analysis]
2 Yu C, Deng X, Xu D. Gene mutations in comorbidity of epilepsy and arrhythmia. J Neurol 2022. [DOI: 10.1007/s00415-022-11430-2] [Reference Citation Analysis]
3 Nikitin ES, Balaban PM, Zaitsev AV. Prospects for Gene Therapy of Epilepsy Using Calcium-Acivated Potassium Channel Vectors. J Evol Biochem Phys 2022;58:1065-1074. [DOI: 10.1134/s0022093022040111] [Reference Citation Analysis]
4 Garofalo B, Bonvin AM, Bosin A, Di Giorgio FP, Ombrato R, Vargiu AV. Molecular Insights Into Binding and Activation of the Human KCNQ2 Channel by Retigabine. Front Mol Biosci 2022;9:839249. [DOI: 10.3389/fmolb.2022.839249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Marini C, Giardino M. Novel treatments in epilepsy guided by genetic diagnosis. Br J Clin Pharmacol 2021. [PMID: 34778987 DOI: 10.1111/bcp.15139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]